Impact of introducing a minimum alcohol tax share in retail prices on alcohol-attributable mortality in the WHO European Region: A modelling study.
Alcohol
Alcohol-attributable burden
Europe
Health tax
Taxation
Journal
The Lancet regional health. Europe
ISSN: 2666-7762
Titre abrégé: Lancet Reg Health Eur
Pays: England
ID NLM: 101777707
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
entrez:
13
5
2022
pubmed:
14
5
2022
medline:
14
5
2022
Statut:
epublish
Résumé
Alcohol use and its burden constitute one of the largest public health challenges in the WHO European Region. Raising alcohol taxes is a cost-effective "best buy" measure to reduce alcohol consumption, but its implementation remains uneven. This paper provides an overview of existing tax structures in 50 countries and subregions of the Region, estimates their proportions of tax on retail prices of beer, wine, and spirits, and quantifies the number of deaths that could be averted annually if these tax shares were raised to a minimum level. Review of databases and statistical reports on taxes and mean retail prices of alcohol beverages in the Region. Affordability was calculated based on alcohol prices, adjusted for differences in purchasing power. Consumption changes and averted mortality were modelled assuming two scenarios. In Scenario 1, a minimum excise tax share level of 25% of the beverage-specific retail price was assumed for all countries. In Scenario 2, in addition to a minimum excise tax share level of 15% it was assumed that per unit of ethanol minimal retail prices were the same irrespective of alcoholic beverages (equalisation). Sensitivity analyses were conducted for different price elasticities. Alcohol is very affordable in the Region and alcohol taxes have clearly been under-utilized as a public health measure, constituting on average only 5·7%, 14·0% and 31·3% of the retail prices of wine, beer, and spirits, respectively. Tax shares were higher in the eastern part of the Region compared to the EU, where various countries did not have excise taxes on wine. Annually, the introduction of a minimum tax share of 25% (Scenario 1) could avert 40,033 (95% CI: 38,054-46,097) deaths in the WHO European Region (with 753,454,300 inhabitants older than 15 years of age). If a 15% tax share with equalisation were implemented (Scenario 2), 132,906 (95% CI: (124,691-151,674) deaths could be averted. All sensitivity analyses with different elasticities yielded outcomes close to those of the main analyses. Similar to tobacco taxes, increasing alcohol taxes should be considered to be a health-based measure aimed at saving lives. Many countries have hesitated to apply higher taxes to alcohol, but the present results show a clear health benefit as a result of implementing a minimum tax share. This work was supported by the National Institute on Alcohol Abuse and Alcoholism (1R01AA028224) and the Canadian Institutes of Health Research, Institute of Neurosciences, and Mental Health and Addiction (SMN-13950).
Sections du résumé
Background
UNASSIGNED
Alcohol use and its burden constitute one of the largest public health challenges in the WHO European Region. Raising alcohol taxes is a cost-effective "best buy" measure to reduce alcohol consumption, but its implementation remains uneven. This paper provides an overview of existing tax structures in 50 countries and subregions of the Region, estimates their proportions of tax on retail prices of beer, wine, and spirits, and quantifies the number of deaths that could be averted annually if these tax shares were raised to a minimum level.
Methods
UNASSIGNED
Review of databases and statistical reports on taxes and mean retail prices of alcohol beverages in the Region. Affordability was calculated based on alcohol prices, adjusted for differences in purchasing power. Consumption changes and averted mortality were modelled assuming two scenarios. In Scenario 1, a minimum excise tax share level of 25% of the beverage-specific retail price was assumed for all countries. In Scenario 2, in addition to a minimum excise tax share level of 15% it was assumed that per unit of ethanol minimal retail prices were the same irrespective of alcoholic beverages (equalisation). Sensitivity analyses were conducted for different price elasticities.
Findings
UNASSIGNED
Alcohol is very affordable in the Region and alcohol taxes have clearly been under-utilized as a public health measure, constituting on average only 5·7%, 14·0% and 31·3% of the retail prices of wine, beer, and spirits, respectively. Tax shares were higher in the eastern part of the Region compared to the EU, where various countries did not have excise taxes on wine. Annually, the introduction of a minimum tax share of 25% (Scenario 1) could avert 40,033 (95% CI: 38,054-46,097) deaths in the WHO European Region (with 753,454,300 inhabitants older than 15 years of age). If a 15% tax share with equalisation were implemented (Scenario 2), 132,906 (95% CI: (124,691-151,674) deaths could be averted. All sensitivity analyses with different elasticities yielded outcomes close to those of the main analyses.
Interpretation
UNASSIGNED
Similar to tobacco taxes, increasing alcohol taxes should be considered to be a health-based measure aimed at saving lives. Many countries have hesitated to apply higher taxes to alcohol, but the present results show a clear health benefit as a result of implementing a minimum tax share.
Funding
UNASSIGNED
This work was supported by the National Institute on Alcohol Abuse and Alcoholism (1R01AA028224) and the Canadian Institutes of Health Research, Institute of Neurosciences, and Mental Health and Addiction (SMN-13950).
Identifiants
pubmed: 35558995
doi: 10.1016/j.lanepe.2022.100325
pii: S2666-7762(22)00018-7
pmc: PMC9088199
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100325Subventions
Organisme : NIAAA NIH HHS
ID : R01 AA028224
Pays : United States
Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
BMC Med. 2020 Mar 9;18(1):55
pubmed: 32146899
Addiction. 2021 Oct;116(10):2673-2684
pubmed: 33751693
Lancet Public Health. 2020 Jan;5(1):e51-e61
pubmed: 31910980
Trends Cardiovasc Med. 2017 Nov;27(8):534-538
pubmed: 28735784
Drug Alcohol Rev. 2021 Mar;40(3):350-367
pubmed: 33155370
Recent Dev Alcohol. 1983;1:303-45
pubmed: 6390555
J Stud Alcohol Drugs. 2021 Jan;82(1):28-41
pubmed: 33573720
Int J Drug Policy. 2020 Jun;80:102636
pubmed: 32417670
BMC Public Health. 2015 May 10;15:482
pubmed: 25958382
Int J Environ Res Public Health. 2020 May 14;17(10):
pubmed: 32423032
Subst Abuse Treat Prev Policy. 2016 Oct 28;11(1):37
pubmed: 27793173
Health Econ Rev. 2013 Jul 24;3(1):17
pubmed: 23883547
Addiction. 2019 Aug;114(8):1489-1494
pubmed: 31148313
Popul Health Metr. 2010 Mar 04;8:3
pubmed: 20202213
Eur J Health Econ. 2020 Aug;21(6):855-867
pubmed: 32236765
Int J Environ Res Public Health. 2019 Oct 04;16(19):
pubmed: 31590298
BMJ. 2008 Nov 06;337:a2364
pubmed: 18988646
Addiction. 2009 Feb;104(2):179-90
pubmed: 19149811
J Stud Alcohol Drugs. 2018 Jul;79(4):514-522
pubmed: 30079865
Pharmacoeconomics. 2021 Jul;39(7):809-822
pubmed: 33970445
Int J Drug Policy. 2022 Jan;99:103420
pubmed: 34456119
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174